Emergent BioSolutions (EBS) Work In Process (2011 - 2018)
Emergent BioSolutions' Work In Process was $103.2 million in Q4 2018, up 34.7% from $76.6 million a year earlier and up 59.2% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Work In Process (2011 - 2018) Analysis & Trends
From Q4 2011 onward, Emergent BioSolutions has reported Work In Process for 28 quarters.
- Work In Process shows a five-year compound annual growth rate of 60.1% (FY2013 to FY2018).
- In earlier years, Work In Process was $76.6 million in FY2017 (+286.5%), $19.82 million in FY2016 (-39.4%), $32.71 million in FY2015 (-2.3%) and $33.48 million in FY2014 (+240.9%).
- The Q4 2018 figure marks the highest quarterly Work In Process in data going back to Q4 2011.
- Compared with a year earlier, Work In Process has increased for five straight quarters, with growth averaging 119.8% over the last eight quarters.
- The best year-over-year quarter for Work In Process over five years was Q3 2018 (growth of 338.7%); the worst was Q3 2017 (a decline of 39.6%).
- Per Business Quant data, EBS's Work In Process in the three quarters before Q4 2018 was $64.83 million (Q3 2018), $79.55 million (Q2 2018) and $82.09 million (Q1 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Emergent BioSolutions | 325.34 Mn | -425.56 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 103.20 Mn |
| Sep 30, 2018 | 64.83 Mn |
| Jun 30, 2018 | 79.55 Mn |
| Mar 31, 2018 | 82.09 Mn |
| Dec 31, 2017 | 76.60 Mn |
| Sep 30, 2017 | 14.78 Mn |
| Jun 30, 2017 | 25.59 Mn |
| Mar 31, 2017 | 27.33 Mn |
| Dec 31, 2016 | 19.82 Mn |
| Sep 30, 2016 | 24.46 Mn |
| Jun 30, 2016 | 41.28 Mn |
| Mar 31, 2016 | 42.35 Mn |
| Dec 31, 2015 | 32.71 Mn |
| Sep 30, 2015 | 34.32 Mn |
| Jun 30, 2015 | 40.86 Mn |
| Mar 31, 2015 | 40.81 Mn |
| Dec 31, 2014 | 33.48 Mn |
| Sep 30, 2014 | 31.38 Mn |
| Jun 30, 2014 | 32.96 Mn |
| Mar 31, 2014 | 33.67 Mn |
API Access
Emergent BioSolutions Work In Process API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=work-in-process&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "work-in-process", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=work-in-process&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();